{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:34:45Z","timestamp":1790638485697,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009085","name":"Jain University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009085","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundacao para a Ciencia e Tecnologia","award":["SFRH\/BPD\/75490\/2010"],"award-info":[{"award-number":["SFRH\/BPD\/75490\/2010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejmech.2015.06.017","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T04:03:41Z","timestamp":1434081821000},"page":"257-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":256,"special_numbering":"C","title":["Recent progress in the drug development of coumarin derivatives as\u00a0potent antituberculosis agents"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-8379","authenticated-orcid":false,"given":"Rangappa S.","family":"Keri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasidhar","family":"B.S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhari Mallanna","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Am\u00e9lia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.06.017_bib1","series-title":"Tuberculosis (online)","year":"2011"},{"key":"10.1016\/j.ejmech.2015.06.017_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis. An important update of current concepts on the clinical, epidemiological and management aspects of tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2015.06.017_bib3","series-title":"Tuberculosis: a Comprehensive Clinical Reference","first-page":"44","author":"Grange","year":"2009"},{"key":"10.1016\/j.ejmech.2015.06.017_bib4","series-title":"World of Scientific Discovery","author":"Robert Koch","year":"2006"},{"key":"10.1016\/j.ejmech.2015.06.017_bib5","series-title":"Textbook of Pharmacology","first-page":"863","author":"Smith","year":"1992"},{"key":"10.1016\/j.ejmech.2015.06.017_bib6","unstructured":"Tuberculosis (Online), http\/\/www.scidev.net, TB and HIV Coinfection, CDC NCHSTP Division of Tuberculosis Elimination."},{"key":"10.1016\/j.ejmech.2015.06.017_bib7","series-title":"Global Tuberculosis Control: Surveillance, Planning, Financing","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.ejmech.2015.06.017_bib8","series-title":"Stop TB Annual Report","doi-asserted-by":"crossref","DOI":"10.30875\/b3a920a4-en","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.ejmech.2015.06.017_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American thoracic society\/centers for disease control and prevention\/infectious diseases society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2015.06.017_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","article-title":"Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation","volume":"157","author":"Goletti","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2015.06.017_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1566524013363933","article-title":"Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis","volume":"1","author":"Mariani","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2015.06.017_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI34614","article-title":"Confronting the scientific obstacles to global control of tuberculosis","volume":"118","author":"Young","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2015.06.017_bib13","first-page":"33","article-title":"Promising drugs against tuberculosis, recent pat. anti-infect","volume":"1","author":"De Souza","year":"2006","journal-title":"Drug Discov."},{"key":"10.1016\/j.ejmech.2015.06.017_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.mcp.0000219264.42686.c9","article-title":"Current status and future prospects for new therapies for pulmonary tuberculosis","volume":"12","author":"De Souza","year":"2006","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.ejmech.2015.06.017_bib15","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.39259.364201.DB","article-title":"WHO launches plan to fight drug resistant tuberculosis","volume":"334","author":"Moszynski","year":"2007","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.ejmech.2015.06.017_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(05)74788-7","article-title":"Can DOTS control multidrug-resistant tuberculosis?","volume":"365","author":"Espinal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2015.06.017_bib17","series-title":"WHO Global Tuberculosis Report","year":"2013"},{"key":"10.1016\/j.ejmech.2015.06.017_bib18","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/518663","article-title":"New tuberculosis therapeutics: a growing pipeline","volume":"196","author":"Spigelman","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2015.06.017_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.coph.2006.06.004","article-title":"Novel targets for tuberculosis drug discovery","volume":"6","author":"Mdluli","year":"2006","journal-title":"Curr. Opin. Pharmacal."},{"key":"10.1016\/j.ejmech.2015.06.017_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(06)68388-8","article-title":"Tuberculosis drug development pipeline: progress and hope","volume":"367","author":"Spigelman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2015.06.017_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nm0307-290","article-title":"Challenges in tuberculosis drug research and development","volume":"13","author":"Ginsberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2015.06.017_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1472-9792(02)00076-8","article-title":"Progress in TB drug development and what is still needed","volume":"83","author":"Duncan","year":"2003","journal-title":"Tuberc. (Edinb.)"},{"key":"10.1016\/j.ejmech.2015.06.017_bib23","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/1381612043383223","article-title":"Identification and validation of novel drug targets in tuberculosis","volume":"10","author":"Duncan","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib24","first-page":"9067","article-title":"Review on oxygen heterocycles","volume":"3","author":"Kaur","year":"2013","journal-title":"Indo Am. J. Pharma. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib25","series-title":"Progress in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0079-6468(08)70267-4","volume":"10","author":"Feuer","year":"1974"},{"key":"10.1016\/j.ejmech.2015.06.017_bib26","series-title":"Heterocyclic Compounds","first-page":"217","author":"Wawzonek","year":"1951"},{"key":"10.1016\/j.ejmech.2015.06.017_bib27","series-title":"Coumarins: Biology Applications and Mode of Action","author":"O'Kennedy","year":"1997"},{"key":"10.1016\/j.ejmech.2015.06.017_bib28","series-title":"The Production and Application of Fluorescent Brightening Agents","author":"Zabradnik","year":"1992"},{"key":"10.1016\/j.ejmech.2015.06.017_bib29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.porgcoat.2014.04.026","article-title":"Synthesis and characterization of coumarin thiazole derivative 2-(2-amino-1,3-thiazol-4-yl)-3H-benzo[f]chromen-3-one with anti-microbial activity and its potential application in antimicrobial polyurethane coating","volume":"77","author":"El-Wahab","year":"2014","journal-title":"Prog. Org. Coat."},{"key":"10.1016\/j.ejmech.2015.06.017_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cclet.2013.01.041","article-title":"An efficient synthesis of some new 3-bipyridinyl substituted coumarins as potent antimicrobial agents","volume":"24","author":"Lad","year":"2013","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ardp.200900188","article-title":"Synthesis, in-vitro antimicrobial and cytotoxic studies of novel azetidinone derivatives","volume":"343","author":"Keri","year":"2010","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2015.06.017_bib32","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1016\/j.bmcl.2010.06.048","article-title":"Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides","volume":"20","author":"Chimenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib33","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.bmcl.2011.02.040","article-title":"Discovery and synthesis of novel 3-phenylcoumarin derivatives as antidepressant agents","volume":"21","author":"Sashidhara","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib34","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.2174\/092986711803414395","article-title":"Coumarins as antioxidants","volume":"18","author":"Kostova","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib35","first-page":"337","article-title":"Inhibitory effect of esculetin on migration, invasion and matrix metalloproteinase-9 expression in TNF-\u03b1-induced vascular smooth muscle cells","volume":"4","author":"Lee","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2015.06.017_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1211\/jpp.62.02.0008","article-title":"Antinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain","volume":"62","author":"Barros","year":"2010","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.06.017_bib37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1747-0285.2011.01195.x","article-title":"Study on the anticancer activity of coumarin derivatives by molecular modeling","volume":"78","author":"Huang","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2009.03.027","article-title":"Effects of umbelliferone in a murine model of allergic airway inflammation","volume":"609","author":"Vasconcelos","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.06.017_bib39","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/jm801240d","article-title":"Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates","volume":"52","author":"Neyts","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib40","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.bmc.2013.01.025","article-title":"Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors","volume":"21","author":"Olomola","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib41","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1016\/j.bmcl.2011.06.074","article-title":"Diversity oriented design of various hydrazides and their in\u00a0vitro evaluation against Mycobacterium tuberculosis H37Rv strains","volume":"21","author":"Manvar","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/jm901570x","article-title":"Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives","volume":"53","author":"Yeh","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib43","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, A\u03b2 aggregation, and \u03b2-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bmcl.2007.09.100","article-title":"Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds","volume":"18","author":"Piazzi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib45","first-page":"129","article-title":"Antioxidative and lipid lowering effects of 7,8-dihydroxy-3-(4-methylphenyl) coumarin in hyperlipidemic rats","volume":"59","author":"Yuce","year":"2009","journal-title":"Arzneim. Forsch. Drug Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib46","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.ejmech.2010.02.048","article-title":"Analgesic, anti-pyretic, DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety","volume":"45","author":"Keri","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib47","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1039\/p19950003135","article-title":"Synthesis of the calophyllum coumarins","volume":"1","author":"Palmer","year":"1995","journal-title":"J.\u00a0Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.ejmech.2015.06.017_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1389557033488006","article-title":"Recent advances in the development of phytoestrogens and derivatives: an update of the promising perspectives in the prevention of postmenopausal diseases","volume":"3","author":"Jacquot","year":"2003","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0223-5234(00)01207-1","article-title":"Substituted benzopyranobenzothiazinones, synthesis and estrogenic activity on MCF-7 breast carcinoma cells","volume":"36","author":"Jacquot","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib50","first-page":"1257","article-title":"Phytomedicines of Europe","volume":"34","author":"Nettleton","year":"1996","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2015.06.017_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1358\/dof.1996.021.08.366798","article-title":"Ensaculin hydrochloride","volume":"21","author":"Noeldner","year":"1996","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2015.06.017_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr60113a001","article-title":"The chemistry of coumarins","volume":"36","author":"Sethna","year":"1945","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2015.06.017_bib53","first-page":"160","volume":"vol. 2","author":"Guibourt","year":"1820"},{"key":"10.1016\/j.ejmech.2015.06.017_bib54","unstructured":"Review of benzypyrone drugs and edema. Lymphoedema.org."},{"key":"10.1016\/j.ejmech.2015.06.017_bib55","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1039\/b808333a","article-title":"The aminocoumarins: biosynthesis and biology","volume":"26","author":"Heide","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2015.06.017_bib56","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.2174\/1381612043382693","article-title":"Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer","volume":"10","author":"Lacy","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib57","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2174\/092986708786242877","article-title":"A\u00a0review of coumarin derivatives in pharmacotherapy of breast cancer","volume":"15","author":"Musa","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/157016206777709393","article-title":"Coumarins as inhibitors of HIV reverse transcriptase","volume":"4","author":"Kostova","year":"2006","journal-title":"Curr. Hiv. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib59","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.bmc.2013.02.017","article-title":"A\u00a0comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease","volume":"21","author":"Patil","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib60","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","article-title":"A\u00a0review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib61","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.2174\/1381612811319210013","article-title":"Current developments of coumarin compounds in medicinal chemistry","volume":"19","author":"Peng","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib62","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/092986710790936284","article-title":"Coumarins: old compounds with novel promising therapeutic perspectives","volume":"17","author":"Riveiro","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib63","first-page":"1091","article-title":"Chemistry and biological activity of coumarins at molecular level","volume":"9","author":"Garro","year":"2014","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2015.06.017_bib64","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.2174\/092986709789578187","article-title":"The structure and pharmacological functions of coumarins and their derivatives","volume":"16","author":"Wu","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib65","first-page":"1","article-title":"Coumarin derivatives: an updated patent review (2012-2014)","volume":"18","author":"Katsori","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2015.06.017_bib66","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2174\/092986706778521968","article-title":"Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents","volume":"13","author":"Kulkarni","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib67","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/cbdd.12044","article-title":"Synthesis and biological evaluation of coumarin derivatives as inhibitors of mycobacterium bovis (BCG)","volume":"80","author":"Rezayan","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1747-0285.2012.01441.x","article-title":"Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity","volume":"80","author":"Naik","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ardp.201000256","article-title":"Synthesis and in-vitro antimycobacterial activity of fluoroquinolone derivatives containing a coumarin moiety","volume":"344","author":"Guo","year":"2011","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2015.06.017_bib70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1747-0285.2011.01120.x","article-title":"Antitubercular activity of new coumarins","volume":"77","author":"Cardoso","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1747-0285.2010.00997.x","article-title":"Screening for in\u00a0vitro antimycobacterial activity and three-dimensional quantitative structure-activity relationship (3D-QSAR) study of 4-(arylamino)coumarin derivatives","volume":"76","author":"Virsdoia","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib72","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.ejmech.2008.01.016","article-title":"Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides","volume":"43","author":"Manvar","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib73a","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1747-0285.2012.01436.x","article-title":"Evaluation of structurally diverse benzoazepines clubbed with coumarins as mycobacterium tuberculosis agents","volume":"80","author":"Upadhyay","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2015.06.017_bib73b","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.bmcl.2011.02.016","article-title":"Synthesis and biological evaluation of 4-styrylcoumarin derivatives as inhibitors of TNF-a and IL-6 with anti-tubercular activity","volume":"21","author":"Upadhyay","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib74","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.bmcl.2012.05.054","article-title":"Synthesis and in\u00a0vitro antitubercular activity of 4-aryl\/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis","volume":"22","author":"Jeyachandran","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib75","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bmcl.2012.12.096","article-title":"Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents","volume":"23","author":"Ahmad","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib76","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1016\/j.bmcl.2013.09.035","article-title":"Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32","volume":"23","author":"Kawate","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.06.017_bib77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2013.12.061","article-title":"Narayanachar, synthesis, structure activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and antimycobacterial agents","volume":"74","author":"Basanagouda","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib78","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1021\/jm4019228","article-title":"Synthetic calanolides with bactericidal activity against replicating and nonreplicating mycobacterium tuberculosis","volume":"57","author":"Zheng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00044-012-0026-x","article-title":"Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl\/benzothiazolyl acetamides as antimicrobial and antituberculosis agents","volume":"22","author":"Patel","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib80a","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00044-012-0073-3","article-title":"In\u00a0vitro antimicrobial and antimycobacterial activity of some chalcones and their derivatives","volume":"22","author":"Patel","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib80b","doi-asserted-by":"crossref","unstructured":"D. Patel, P. Kumari, N. B. Patel, Synthesis and biological evaluation of coumarin based isoxazoles, pyrimidinthiones and pyrimidin-2-ones, Arab. J. Chem. (in press) DOI: 10.1016\/j.arabjc.2014.06.010.","DOI":"10.1016\/j.arabjc.2014.06.010"},{"key":"10.1016\/j.ejmech.2015.06.017_bib81","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00044-012-0222-8","article-title":"Coumarinyl pyrazole derivatives of INH: promising antimycobacterial agents","volume":"22","author":"Palkar","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib82","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1007\/s00044-012-0437-8","article-title":"One pot synthesis of some novel coumarins containing 5-(substituted-2-hydroxybenzoyl) pyridine as a new class of antimicrobial and antituberculosis agents","volume":"22","author":"Bhila","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib83","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s00044-013-0850-7","article-title":"Design, synthesis, and evaluation of 4-(substituted)phenyl- 2-thioxo-3,4-dihydro-1H-chromino[4,3-d]pyrimidin-5-one and 4-(substituted)phenyl-3,4-dihydro-1H-chromino[4,3-d]pyrimidine-2,5-dione analogs as antitubercular agents","volume":"23","author":"Ambre","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cbpa.2005.02.010","article-title":"Metal complex-DNA interactions: from transcription inhibition to photoactivated cleavage","volume":"9","author":"Boerner","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2015.06.017_bib85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejmech.2009.10.005","article-title":"Antimicrobial and SOD activities of novel transition metal complexes of pyridine-2,6-dicarboxylic acid containing 4-picoline as auxiliary ligand","volume":"45","author":"Siddiqi","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib86a","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1021\/ic0111738","article-title":"Oxidative damage by ruthenium complexes containing the dipyridophenazine ligand or its derivatives: a focus on intercalation","volume":"41","author":"Delaney","year":"2002","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib86b","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1080\/00958970903261317","article-title":"Ligational behavior of a bidentate coumarin derivative towards CoII, NiII, and CuII: synthesis, characterization, electrochemistry, and antimicrobial studies","volume":"62","author":"Budagumpi","year":"2009","journal-title":"J.\u00a0Coord. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib87","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/aoc.2907","article-title":"Spectral, thermal, biological and multi-heating rate kinetic properties of Cu(II) complexes containing N2O2 donor ligands: 1,10-phenanthroline and acyl coumarins","volume":"26","author":"Patel","year":"2012","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2015.06.017_bib88","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1007\/s00044-014-0943-y","article-title":"Cu(II) and Ni(II) complexes of coumarin derivatives with fourth generation flouroquinolone: synthesis, characterization, microbicidal and antioxidant assay","volume":"23","author":"Patel","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4236\/ojmetal.2012.23008","article-title":"Synthesis of Cu(II), Ni(II), Co(II), and Mn(II) complexes with ciprofloxacin and their evaluation of antimicrobial, antioxidant and antitubercular activity","volume":"2","author":"Patel","year":"2012","journal-title":"Open. J. Metal."},{"key":"10.1016\/j.ejmech.2015.06.017_bib90","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.saa.2012.05.057","article-title":"Multiple heating rate kinetic parameters, thermal, X-ray diffraction studies of newly synthesized octahedral copper complexes based on bromo-coumarins along with their antioxidant, antitubercular and antimicrobial activity evaluation","volume":"96","author":"Patel","year":"2012","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.ejmech.2015.06.017_bib91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.saa.2012.09.096","article-title":"Dicoumarol complexes of Cu(II) based on 1,10-phenanthroline: synthesis, X-ray diffraction studies, thermal behavior and biological evaluation","volume":"108","author":"Dholariya","year":"2013","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.ejmech.2015.06.017_bib92","first-page":"1","article-title":"Studies of newly synthesized octahedral copper complexes based on coumarins along with their antioxidant, anti-tubercular and antimicrobial activity evaluation","volume":"1","author":"Patel","year":"2014","journal-title":"J.\u00a0Club App. Sci."},{"key":"10.1016\/j.ejmech.2015.06.017_bib93","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.saa.2011.03.032","article-title":"Antitubercular and fluorescence studies of copper(II) complexes with quinolone family member, ciprofloxacin","volume":"79","author":"Kharadi","year":"2011","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.ejmech.2015.06.017_bib94","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/np030096l","article-title":"Natural products as sources of new drugs over the period 1981-2002","volume":"66","author":"Newman","year":"2003","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2015.06.017_bib95","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1211\/0022357011775712","article-title":"Ethnopharmacology in drug discovery: an analysis of its role and potential contribution","volume":"53","author":"Heinrich","year":"2001","journal-title":"J.\u00a0Pharma. Pharmac."},{"key":"10.1016\/j.ejmech.2015.06.017_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jps.2600530302","article-title":"Naturally occurring coumarins and related physiological activities","volume":"53","author":"Soine","year":"1964","journal-title":"J.\u00a0Pharma. Sci."},{"key":"10.1016\/j.ejmech.2015.06.017_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/963248","article-title":"Review on natural coumarin lead compounds for their pharmacological activity","author":"Venugopala","year":"2013","journal-title":"Biomed. Res. Inter."},{"key":"10.1016\/j.ejmech.2015.06.017_bib98","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1021\/np049706n","article-title":"Antimycobacterial coumarins from the sardinian giant fennel (Ferula communis)","volume":"67","author":"Appendino","year":"2004","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2015.06.017_bib99","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/cbdv.200900326","article-title":"A\u00a0novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa","volume":"7","author":"Chiang","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2015.06.017_bib100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2003-37716","article-title":"Coumarins and carbazoles from Clausena excavata exhibited antimycobacterial and antifungal activities","volume":"69","author":"Sunthitikawinsakul","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2015.06.017_bib101","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.3390\/molecules17078471","article-title":"Antimycobacterial activity of constituents from Foeniculum vulgare Var. Dulce grown in Mexico","volume":"17","author":"Esquivel-Ferri\u00f1o","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2015.06.017_bib102","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12272-011-0402-y","article-title":"C-7 oxygenated coumarins from the fruits of Micromelum minutum","volume":"34","author":"Lekphrom","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2015.06.017_bib103","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0031-9422(99)00615-9","article-title":"Indicanines B and C, two isoavonoid derivatives from the root bark of Erythrina indica","volume":"53","author":"Waffo","year":"2000","journal-title":"Phytochemistry"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T09:30:28Z","timestamp":1717925428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415300908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":106,"alternative-id":["S0223523415300908"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.06.017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress in the drug development of coumarin derivatives as\u00a0potent antituberculosis agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}